Literature DB >> 2498311

Mutagenesis of bacterial elongation factor Tu at lysine 136. A conserved amino acid in GTP regulatory proteins.

Y W Hwang1, A Sanchez, D L Miller.   

Abstract

We have studied the effects of specific amino acid replacements in EF-Tu upon the protein's interactions with guanine nucleotides and elongation factor Ts (EFTs). We found that alterations at the lysine residue of the Asn-Lys-Cys-Asp sequence, the guanine ring-binding sequence, differentially affect the protein's ability to bind guanine nucleotides. Wild type EF-Tu (Lys-136) binds GDP and GTP much more tightly than do many of the altered proteins. Replacing lysine by arginine lowers the protein's affinity for GDP by about 20-fold relative to the change in its affinity for EF-Ts. Substitutions at residue 136 by glutamine (K136Q) and glutamic acid (K136E) further lower the protein relative affinity for GDP by factors of about 4 and 10, respectively. In contrast, replacement of the residue by isoleucine (K136I) eliminates guanine nucleotide binding as well as EF-Ts binding. Apparently, the distortion of this loop by substitution at residue 136 of a bulky hydrophobic residue can hamper the binding for both substrates or disrupt the folding of the protein. All altered proteins except EF-Tu(K136I) are able to bind tRNA(Phe); however, they require much higher concentrations of GTP than wild type EF-Tu. In minimal media, Escherichia coli cells harboring plasmids encoding EF-Tu(K136E) or EF-Tu(K136Q) suffer growth retardation relative to cells bearing the same plasmid encoding wild type EF-Tu. Co-transformation of these cells with a compatible plasmid bearing the EF-Ts gene reverses this growth problem. The growth retardation effect of some of the altered proteins can be explained by their sequestering EF-Ts. These results indicate that EF-Ts is essential to the growth of E. coli and suggest a technique for studying EF-Ts mutants as well as for identifying other guanine nucleotide exchange enzymes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498311

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Characterization of DRGs, developmentally regulated GTP-binding proteins, from pea and Arabidopsis.

Authors:  M L Devitt; K J Maas; J P Stafstrom
Journal:  Plant Mol Biol       Date:  1999-01       Impact factor: 4.076

2.  GTP hydrolysis by eRF3 facilitates stop codon decoding during eukaryotic translation termination.

Authors:  Joe Salas-Marco; David M Bedwell
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

3.  Protein engineering and site-directed mutagenesis. Patents and literature.

Authors:  J S Dordick
Journal:  Appl Biochem Biotechnol       Date:  1990-10       Impact factor: 2.926

4.  GTPase domains of ras p21 oncogene protein and elongation factor Tu: analysis of three-dimensional structures, sequence families, and functional sites.

Authors:  A Valencia; M Kjeldgaard; E F Pai; C Sander
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

5.  Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.

Authors:  Z Su; N I Goldstein; P B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

6.  The TRAPP complex is a nucleotide exchanger for Ypt1 and Ypt31/32.

Authors:  S Jones; C Newman; F Liu; N Segev
Journal:  Mol Biol Cell       Date:  2000-12       Impact factor: 4.138

7.  A single amino acid substitution in elongation factor Tu disrupts interaction between the ternary complex and the ribosome.

Authors:  I Tubulekas; D Hughes
Journal:  J Bacteriol       Date:  1993-01       Impact factor: 3.490

8.  Molecular cloning and expression of a G25K cDNA, the human homolog of the yeast cell cycle gene CDC42.

Authors:  S Munemitsu; M A Innis; R Clark; F McCormick; A Ullrich; P Polakis
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

9.  Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display.

Authors:  R Shen; Z Z Su; C A Olsson; P B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

10.  Protein synthesis during cellular quiescence is inhibited by phosphorylation of a translational elongation factor.

Authors:  Sandro F F Pereira; Ruben L Gonzalez; Jonathan Dworkin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.